We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Periocular actinic keratosis and squamous cell carcinoma ...

March 9, 2010 (Miami Beach, Florida) — The new 0.05% ingenol mebutate gel (currently called PEP005) is effective and well tolerated when used to treat actinic keratoses (AK) on sites such as the chest ...

The epidemiology of actinic keratosis varies throughout the world according to the genetic makeup and skin type of the population and their lifestyle habits, specifically time spent in the sun. The ...

PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps that are ...

Treatment for seborrheic keratosis is usually unnecessary. However, a person may choose to treat it with cryotherapy, shave excision, laser therapy, topical medications, or electrodesiccation with or ...

Actinic Keratosis (AK) is a precancerous skin lesion that appear on areas of the skin damaged by chronic exposure to ultraviolet (UV) rays from the sun and/or indoor tanning. Solar keratosis is ...

A combination of two FDA-approved drugs - a topical chemotherapy and an immune-system-activating compound - was able to rapidly clear actinic keratosis lesions from patients participating in a ...

What's new concerning our understanding of actinic keratosis? Find out in this easy-to-navigate collection of recent MEDLINE abstracts compiled by the editors at Medscape Dermatology. Imiquimod 5% ...

BUFFALO, N.Y., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for ...

Actinic Keratosis or Solar Keratosis is a pre-cancerous condition characterized by thick, rough, dry and scaly or crusty patches caused due to long, perennial exposure to sun. The patches or lesions ...

LONDON, UNITED KINGDOM, December 11, 2025 /EINPresswire.com/ -- Vidac Pharma Holdings Plc Announces Initiation of Phase 2B* Clinical Trial for Targeted Treatment of ...